These results provide evidence that using cGAMP stimulates and enhances the innate immune response through the cGAS-cGAMP-STING-IRF3 pathway, and increases antitumor cytokines production and DCs activation to inhibit tumor growth. Here, STING1 is linked to neoplasm.